Humacyte (HUMA) Insider buying
5 open-market purchases of HUMA by Humacyte's executives and directors since May 2026, worth $90,209 in total, from SEC Form 4 filings.
Summary
The most recent: Keith Anthony Jones, Director bought $5,620 on September 14, 2026.
The biggest buyer over the period is Kathleen Sebelius (Director): 1 purchase, $50,000.
By year
| Year | Purchases | Value |
|---|---|---|
| 2026 | 5 | $90,209 |
Biggest buyers
| Insider | Buys | Value |
|---|---|---|
| Kathleen Sebelius Director | 1 | $50,000 |
| Keith Anthony Jones Director | 3 | $30,370 |
| Michael T. Constantino Director | 1 | $9,840 |
Every purchase
Newest first. From SEC Form 4 filings. Insider buying across the market.
| Date | Insider | Shares | Price | Value | Filing |
|---|---|---|---|---|---|
| Sep 14, 2026 | Anthony Jones Keith Director |
10,000 | $0.56 | $5,620 | Form 4 |
| Aug 20, 2026 | Anthony Jones Keith Director |
10,000 | $0.69 | $6,930 | Form 4 |
| Aug 17, 2026 | Anthony Jones Keith Director |
30,000 | $0.59 | $17,820 | Form 4 |
| May 19, 2026 | Sebelius Kathleen Director |
56,818 | $0.88 | $50,000 | Form 4 |
| May 18, 2026 | T. Constantino Michael Director |
11,000 | $0.89 | $9,840 | Form 4 |
Questions about Humacyte
Are Humacyte insiders buying the stock?
5 open-market purchases of HUMA by Humacyte's executives and directors since May 2026, worth $90,209 in total, from SEC Form 4 filings. The most recent: Keith Anthony Jones, Director bought $5,620 on September 14, 2026.
What counts as insider buying here?
Open-market purchases (Form 4 code P) by officers and directors. Option exercises, grants and purchases by 10% owners are left out.
From Humacyte's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.